Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165658 · ClinicalTrials.gov registry record · Phase 1
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01165658: Clinical Trial Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT01165658 is a Phase 1 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01165658, a Phase 1 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to study the safety of giving larger daily doses of proton radiation therapy than the standard dose levels given to treat lung cancer. Researchers want to find the highest daily dose of proton radiation that can be given without having to stop therapy due to side effects.
Interventions
- RADIATION Proton Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-07-16 |
| Est. Completion | 2016-07-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01165658
The ClinicalTrials.gov registry entry for NCT01165658 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Therapy is the first listed.
NCT01165658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01165658 about?
NCT01165658 is a clinical study titled "Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies". The goal of this clinical research study is to study the safety of giving larger daily doses of proton radiation therapy than the standard dose levels given to treat lung cancer. Researchers want to find the highest daily dose of proton radiation that can be given without having to stop therapy due ...
What is the current status of trial NCT01165658?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-07-16. Estimated completion is 2016-07-19.
What interventions are being tested in trial NCT01165658?
The interventions under investigation include: Proton Therapy (RADIATION).
Who is sponsoring clinical trial NCT01165658?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.